Mark Gardner

Mark Gardner is Senior Vice President, Molecular Genomics and Oncology for Quest Diagnostics.

In this role, Mark is responsible for driving growth in Quest’s Advanced Diagnostics offerings by providing genetic sequencing services, cancer diagnostics and working closely with all the clinical franchises.

Mark joined Quest in 2022 from Corza Medical, a private equity operating company focused on surgical technologies and tools, where he served as Executive Partner, Senior Vice President and General Manager of European Commercial Operations and Biosurgery Products. Prior to that, Mark served in leadership positions at a range of companies including Thermo Fisher Scientific, Life Technologies, Invitrogen and Omniseq. He started his civilian career as a consultant with the global management consulting firm McKinsey & Company, after leaving the U.S. Navy, where he was a Lieutenant Commander.

Mark earned an MBA from the Wharton School at the University of Pennsylvania, a master’s degree in national security studies from Georgetown University, and a bachelor’s degree from the U.S. Naval Academy.